Effect of constant administration of a gonadotropin-releasing hormone agonist on reproductive activity in mares: preliminary evidence on suppression of ovulation during the breeding season.
Abstract: During the breeding season, the effect of constant administration of an agonist analog of gonadotropin-releasing hormone (GnRH; goserelin acetate) on reproductive activity of mares was determined. Twenty-four mares undergoing estrous cycles were allocated at random to 6 groups (n = 4/group) and, on May 29 (day 0), received no treatment (group 1, controls), 120 micrograms (group 2), 360 micrograms (group 3), 600 micrograms (group 4), or 1,200 micrograms (group 5) of GnRH agonist/d for 28 days via a depot implanted subcutaneously. The final group of mares (group 6) was treated with 120 micrograms of GnRH agonist/d for 84 days (3 occasions at 28-day intervals). During a pretreatment period (April 19 to May 29) and for 90 days after initiation of GnRH agonist treatment, follicular development and ovulation were monitored by transrectal ultrasonography of the reproductive tract at 2- to 3-day intervals. On each occasion a blood sample was collected for determination of luteinizing hormone (LH) and progesterone. Estrous behavior was monitored by teasing of mares with a stallion. Initiation of agonist treatment was random, relative to the stage of the estrous cycle, and all mares ovulated within 11 days before or after implantation. In 3 of 4 nontreated control mares, estrous cycles were observed throughout the study, with interovulatory intervals ranging from 18 to 26 days. In the remaining mare, concentration of progesterone was high after asynchronous double ovulation during the pretreatment period, suggestive of persistent corpus luteum.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1993-10-01 PubMed ID: 8250402
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study explored the impact of administering a gonadotropin-releasing hormone agonist consistently on the reproductive activity of mares during the breeding season. Notably, preliminary evidence displayed ovulation suppression in mares during the breeding season.
Study Design and Methodology
- Twenty-four mares exhibiting estrous cycles were randomly divided into six groups. Four mares were selected for each group.
- On the designated day (May 29), mares in different groups received different treatments. While the control group did not receive any treatment, the others received varying doses (ranging from 120 micrograms to 1,200 micrograms) of a gonadotropin-releasing hormone (GnRH) agonist per day for 28 days through a subcutaneously implanted depot. The final group received 120 micrograms/day of the GnRH agonist for 84 days, administered three times at 28-day intervals.
- A pretreatment period was observed from April 19 to May 29. After this period and for the subsequent 90 days, researchers monitored the follicular development and ovulation using transrectal ultrasonography at every 2 to 3 days interval.
- Blood samples were collected on each occasion to evaluate the luteinizing hormone (LH) and progesterone levels.
- Estrous behavior of the mares was monitored by teasing with a stallion.
- The stage of the estrous cycle at the time of initiating the agonist treatment was random, and all mares in the study ovulated either 11 days before or after the treatment.
Observations and Findings
- Three out of four mares in the control group exhibited estrous cycles throughout the study duration, with their interovulatory intervals ranging from 18 to 26 days.
- In contrast, one mare from the control group had an elevated progesterone concentration noticeable after asynchronous dual ovulation during the pretreatment phase. This particular mare suggested the presence of a persistent corpus luteum, pointing towards ovarian conditions.
Significance of the study
- The research sheds light on how the administration of a GnRH agonist can influence the reproductive activity of mares during the breeding season.
- The preliminary findings suggest that constant administration of a GnRH agonist could suppress ovulation in mares during the breeding season. This could lay down the foundation for developing reproductive control methods in equine species. However, further thorough research would be required to confirm these initial observations.
Cite This Article
APA
Fitzgerald BP, Peterson KD, Silvia PJ.
(1993).
Effect of constant administration of a gonadotropin-releasing hormone agonist on reproductive activity in mares: preliminary evidence on suppression of ovulation during the breeding season.
Am J Vet Res, 54(10), 1746-1751.
Publication
Researcher Affiliations
- Department of Veterinary Science, Maxwell Gluck Equine Research Center, University of Kentucky, Lexington 40546-0099.
MeSH Terms
- Animals
- Breeding / methods
- Drug Administration Schedule
- Female
- Goserelin / administration & dosage
- Goserelin / pharmacology
- Horses / blood
- Horses / physiology
- Luteinizing Hormone / blood
- Ovulation / drug effects
- Ovulation / physiology
- Progesterone / blood
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists